Abstract
Clinical and experimental evidence suggests that, as an overall strategy, radiotherapy for most cancers should be given using the smallest practical dose per fraction and the shortest overall treatment duration. Any attempt to modify standard fractionation patterns to use smaller dose fractions and or a shorter overall time will require more than 5 fractions per week. However, the fact that both strategies result in 2 or more treatments on some or every treatment day should not obscure the different biological reasons for adopting them. Shortening the overall treatment time (accelerated fractionation) aims to minimize the effect of regeneration of tumor clonogens during treatment while the use of small dose fractions (hyperfractionation) is aimed at exploiting differences in the radio-biology of the tumor and late responding normal tissues. Hyperfractionation is the use of dose fractions smaller than standard. Accelerated fractionation is a shortening of the overall duration of a fractionated dose regimen. (Hyperfractionated accelerated treatment involves both a reduced dose per fraction and a shorter overall time.)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ang KK, van der Kogel AJ, van Dam J, van der Schueren E (1984) The kinetics of repair of sublethal damage in the rat cervical spinal cord during fractionated irradiation. Radiother Oncol 1: 247–253
Ang KK, Xu F-X, Vanuytsel L, van der Schueren E (1985) Repopulation kinetics in irradiated mouse lip mucosa: The relative importance of treatment protraction and time distribution of irradiations. Radiat Res 101: 162–169
Arcangeli G, Mauro F, Morelli D, Nervi C (1979) Multiple daily fractionation in radiotherapy: Biological rationale and preliminary clinical experiences. Europ J Cancer 15: 1077–1083
Backstrom A, Jakobsson DA, Littbrand B, Wersall J (1973) Fractionation scheme with low individual doses in irradiation of carcinomas of the mouth. Acta Radiol Ther Phys Biol 12: 401–406
Barendsen GW (1982) Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8: 1981–1997
Cox JD (1985) Large dose fractionation (hypofractionation). Cancer 55: 2105–2111
Douglas B, Worth A (1982) Superfractionation in glioblastoma multiforme: Results of a phase II study. Int J Radiat Oncol Biol Phys 8: 1787–1794
Edsmyr F, Andersson L, Esposti PL, Littbrand B, Nilsson B (1985) Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 4: 197–203
Ellis F (1969) Dose, time and fractionation: A clinical hypothesis. Clin Radiol 20: 1–7
Horiot JC, Nabid A, Chapman G (1982) Clinical experience with multiple daily fractionation in the radiotherapy of head and neck carcinoma. Cancer Bulletin 34: 230–233
Horiot JC, van den Bogaert W, de Pauw M, van Glabbeke M, Gonzales DG, van der Schueren E (1985) EORTC prospective trials of altered fractionation using multiple fractions per day (MFD). Proceedings 16th Int. Congress of Radiology, Honolulu, Hawaii, 1985, p 95
Horiot JC, Chaplain G, van der Schueren E et al. (1985) European Organization for Research and Treatment on Cancer (EORTC) Cooperative Group of Radiotherapy: Protocol 22581 “A phase III study of accelerated fractionation in the radiotherapy of advanced head and neck carcinoma”
Jampolis S, Pepard G, Horiot JC, Bolla M, LeDorze C (1977) Preliminary results using twice a day fractionation in the radiotherapeutic management of advanced cancers of the head and neck. Am J Roentgenol 129: 1091–1093
Littbrand B, Edsmyr F, Revesz L (1975) A low dose fractionation scheme for the radiotherapy of the carcinoma of the bladder. Experimental and preliminary results. Bull Cancer 62: 241
Loeffler RK (1983) Improved tolerance with two radiation fractions per day for treatment of abdominal and pelvic malignancies. Am J Clin Oncol (CCT) 6: 619–627
Maciejewski B, Taylor JMG, Withers HR (1986 a) Alpha beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx. Radiother Oncol 4: 323–326
Maciejewski B, Withers HR, Taylor JMG, Hliniak A (1986b) Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 1. Tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys (submitted)
Mason KA, Withers HR (1977) RBE of neutrons generated by 50 MeV deuterons on beryllium for control of artificial pulmonary metastases of a mouse fibrosarcoma. Br J Radiol 50: 652–657
Medini E, Rao Y, Kim T, James TK, Levitt SH (1980) Radiation therapy for advanced head and neck squamous cell carcinoma using twice-a-day fractionation. Radiology 134: 531–532
Meoz RT, Fletcher GH, Peters LJ, Barkley HT, Thames HD (1984) Twice-daily fractionation schemes for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 10: 831–836
Parsons JT, Cassisi NJ, Million RR (1984) Results of twicea-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 10: 2041–2051
Parsons JT, Cassisi NJ, Million RR (1984) Results of twicea-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 10: 2041–2051
Parsons JT, Cassisi NJ, Million RR (1984) Results of twicea-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 10: 2041–2051
Peters LJ, Ang KK (1987) Accelerated fractionation. In: Withers HR, Peters U (eds) Innovations in Radiation Oncology. Springer-Verlag, Heidelberg
Regaud C (1929) Radium therapy of cancer at the Radium Institute of Paris. Technique, biological principles and results. Am J Roentgenol Rad Therapy 21: 1–24
Revesz L, Littbrand B, Midander J, Scott OCA (1975) Oxygen effects in the shoulder region of cell survival curves. In: Alper T (ed) Proceedings 6th LH Gray Conference. John Wiley and Sons Ltd, London New York, p 141
Schwarz G (1914) Dauerbestrahlung mit täglichen kleinen Dosen. Münchener Med Wochenschr 61: 1733–1735
Shukovsky L, Fletcher GH, Montague ED, Withers HR (1976) Experience with twice-daily fractionation in clinical radiotherapy. Am J Roentgenol 126: 155–162
Singh K (1978) Two regimes with the same TDF but differing morbidity used in the treatment of stage III carcinoma of the cervix. Br J Radiol 51: 357–362
Thames HD, Withers HR, Peters U, Fletcher GH (1982) Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 8: 219–226
Trott K, Kummermehr J (1985) What is known about tumor proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol 3: 1–9
van der Schueren E, van den Bogaret W, Ang KK (1983) Radiotherapy with multiple fractions per day. In: Steel GG, Adams GE, Peckham MJ (eds) The Biological Basis of Radiotherapy. Elsevier Science Publishers, Amsterdam, p 195
Vegesna V, Withers HR, Thames HD (1985) Multifraction radiation response of mouse lung. Int J Radiat Biol 47: 413–422
Wang CC, Blitzer PH, Suit H (1985) Twice-a-day radiation therapy for cancer of the head and neck. Cancer 55: 2100–2104
Wang CC, Suit HD, Blitzer PH (1986) Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat On-col Biol Phys 12: 3–7
Wang CC (1987) Accelerated fractionation. In: Withers HR, Peters U (eds) Innovations in Radiation Oncology. Springer-Verlag, Heidelberg
Withers HR (1972) Cell renewal concepts and the radiation response. In: Vaeth JM (ed) Frontiers of Radiation Therapy and Oncology, vol 6. Karger, Basel, p 93
Withers HR (1975) Cell cycle redistribution as a factor in multifraction irradiation. Radiology 114: 199–202
Withers HR, Hunter N, Barkley HT, Reid BO (1974) Radiation survival and regeneration characteristics of spermatogenic stem cells of mouse testis. Radiat Res 57: 88–103
Withers HR, Thames HD Jr, Peters U (1982a) Differences in the fractionation response of acute and late responding tissues, In: Karcher KH, Kogelnik HD, Reinartz G (eds) Progress in Radio-Oncology II. Raven Press, New York, p 287
Withers HR, Thames HD Jr, Peters LJ (1982b) Biological bases for high RBE values for late effects of neutron irradiation. Int J Radiat Oncol Biol Phys 8: 2071–2076
Withers HR, Thames HD, Peters LJ, Fletcher GH (1983a) Normal tissue radioresistance in clinical radiotherapy. In: Fletcher GH, Nervi C, Withers HR (eds) Biological Bases and Clinical Implications of Tumor Radioresistance. Masson, New York, p 139
Withers HR, Thames HD, Peters U (1983 b) A new isoeffect curve for change in dose per fraction. Radiother Oncol 2: 187–192
Withers HR (1985) Biologic basis for altered fractionation schemes. Cancer 55: 2086–2095
Withers HR, Mason KA, Thanes HD (1986) Late radiation response of kidney assayed by tubule cell survival. Br J Radiol 59: 587–595
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Withers, H.R., Horiot, JC. (1988). Hyperfractionation. In: Withers, H.R., Peters, L.J. (eds) Innovations in Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83101-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-83101-0_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83103-4
Online ISBN: 978-3-642-83101-0
eBook Packages: Springer Book Archive